SGOC [SGOCO] SC 13G/A: CUSIP No. 406548107 SCHEDULE 13G Page 2 of
[CUSIP No. 406548107 SCHEDULE 13G Page 2 of 10 1 NAMES OF REPORTING PERSONS 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP o (a) (b) þ 3 SEC USE ONLY 4]
SGOC [SGOCO] SC 13G/A: (Original Filing)
[SECURITIES & EXCHANGE COMMISSION SCHEDULE 13G (Amendment No 1)* Hambrecht Asia Acquisition Corp (Name of Issuer) Common Stock (Title of Class of Securities) 406548107 (CUSIP Number) Alexander H. McMillan, Esq. c/o Loeb Partners Corporation 61 Broadway, New York, N.Y. 10006 (212) 483-7069 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) March 8, 2010 (Date of]
SGOC [SGOCO] SC 13G/A: SECURITIES & EXCHANGE COMMISSION SCHEDULE 13G (Amendment No
[SECURITIES & EXCHANGE COMMISSION SCHEDULE 13G (Amendment No 1)* Hambrecht Asia Acquisition Corp (Name of Issuer) Common Stock (Title of Class of Securities) 406548107 (CUSIP Number) Alexander H. McMillan, Esq. c/o Loeb Partners Corporation 61 Broadway, New York, N.Y. 10006 (212) 483-7069 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) March 8, 2010 (Date of]
SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] SC 13G/A: (Original Filing)
[SCHEDULE 13G 3 (Amendment No. Skystar Bio-Pharmaceutical Company (Name of Issuer) Common Stock 830884102 May 05, 2009 o x o * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures]
SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] SC 13G/A: SCHEDULE 13G 3 (Amendment No. Skystar Bio-Pharmaceutical Company
[SCHEDULE 13G 3 (Amendment No. Skystar Bio-Pharmaceutical Company (Name of Issuer) Common Stock 830884102 May 05, 2009 o x o * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures]
SKBI [SKYSTAR BIO-PHARMACEUTICAL] SC 13G/A: (Original Filing)
[SCHEDULE 13G 3 (Amendment No.ystar Bio-Pharmaceuticalmpany (Name of Issuer)mmon Stock 830884102 May05,2009 o x o * The remainder of thisver page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendmentntaining information which wouldter the disclosures provided in a]
SKBI [SKYSTAR BIO-PHARMACEUTICAL] SC 13G/A: SCHEDULE 13G 3 (Amendment No.ystar Bio-Pharmaceuticalmpany (Name of
[SCHEDULE 13G 3 (Amendment No.ystar Bio-Pharmaceuticalmpany (Name of Issuer)mmon Stock 830884102 May05,2009 o x o * The remainder of thisver page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendmentntaining information which wouldter the disclosures provided in a]
CSUN [China Sunergy] SC 13G/A: (Original Filing)
[(Name of Issuer) Ordinary Shares (Title of Class of Securities) G84381 105 (CUSIP Number) December 31, 2009 (Date of Event Which Requires Filing of this Statement) o o x *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent]
CSUN [China Sunergy] SC 13G/A: (Name of Issuer) Ordinary Shares (Title of Class
[(Name of Issuer) Ordinary Shares (Title of Class of Securities) G84381 105 (CUSIP Number) December 31, 2009 (Date of Event Which Requires Filing of this Statement) o o x *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent]
CSUN [China Sunergy] SC 13G/A: (Original Filing)
[(Name of Issuer) Ordinary Shares (Title of Class of Securities) G84381 105 (CUSIP Number) December 31, 2009 (Date of Event Which Requires Filing of this Statement) o o x *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent]
